-
Beth Plale named executive director of IU Pervasive Technology Institute
Plale just returned to IU following a three-year stint at the National Science Foundation as science advisor for public access.
-
Survey: Majority of Hoosiers view university, policymaker collaboration as crucial for Indiana
The survey reveals that three out of four Hoosiers agree that universities have a responsibility to help improve their communities.
-
IU lab wins $8 million award in pursuit of 3D tracking of first responders
The IU lab will administer a series of competitions to find the best solution for keeping track of first responders during emergencies.
-
Blood test for depression, bipolar disorder offers promise of personalized treatment
An IU School of Medicine study sheds light on the biological basis of mood disorders and offers a precision-medicine approach to treatment.
-
IU mourns passing of J. Michael Dunn, founding dean emeritus of Luddy School
Dunn helped develop the nation's first school of informatics into one of the nation's largest, broadest and best schools of its kind.
-
O'Neill School remains near top of U.S. News graduate school rankings
Graduate programs in public and environmental affairs, business, education, and medicine are ranked highly by U.S. News and World Report.
-
Methadone research could help babies exposed to opioids in utero
The findings could one day lead to new treatment options that reduce long-term damage to babies from in-utero exposure to opioids.
-
IUPUI chemistry graduate student recognized for volunteerism
Christine Skaggs was named ACS Global Outreach Volunteer of the Year for work helping children from underserved populations in Indianapolis.
-
Digital twins could lead to more proactive, personalized medicine, IU researchers say
Professor James Glazier says the use of digital twins could be applied to the human body and lead to better health care outcomes.
-
Could rotavirus genome be key to COVID-19 vaccine for kids? IU researchers say yes.
IU researchers are reverse-engineering the rotavirus genome to explore the possibility of a combined rotavirus-COVID-19 vaccine.
